Over the summer, we took a deep dive into “Ozempic Face,” a phenomenon that occurs when quick, significant weight loss leads ...

The FDA has resolved Eli Lilly's tirzepatide shortage, but localized supply issues persist. Meanwhile, Hims & Hers Health's ...

Ozempic and similar drugs are often effective because they produce feelings of satisfaction, in line with the NBC theory of ...

Image credit Weight loss is an incredible journey; if you’ve been through it, you know how frustrating and overwhelmin ...

GLP-1 drugs such as Ozempic and Wegovy are providing new challenges for diet brands and gyms, who have seen a surge in demand ...

NBC 7 dives deep into the explosive popularity of the medications and explores both the life-changing benefits and the ...

Eli Lilly's weight-loss drug Zepbound and diabetes medication Mounjaro are no longer in short supply. That could limit ...

The San Francisco telehealth company had capitalized on the shortage by making copycat versions of popular brand-name GLP-1 ...

Telehealth companies and patients are grappling with the potential loss of access to cheaper, alternative versions of Eli ...

The FDA has removed two of Eli Lilly's in-demand weight-loss and diabetes drugs from its shortage list. Diabetes drug ...

Digbi Health, a leader in Precision Biology and personalized healthcare, has been invited to present a landmark study at the ...

Hims & Hers' (HIMS) stock drop marks the latest overhang on a company that has more than doubled in value over the past 12 ...